<DOC>
	<DOCNO>NCT01864733</DOCNO>
	<brief_summary>The treatment chronic heart failure ( CHF ) key challenge public health . Despite medical advance , 1-year mortality NYHA III-IV CHF 28 % . Undernutrition independent risk factor mortality complication . Up-to-date , interventional study involve nutrition scarce CHF . Academic society recommend use oral nutritional supplement ( ONS ) case weight loss , without define modality . ONS could improve nutritional status undernourished CHF patient , solely administer , limited impact undernutrition , physical performance prognosis . A multimodal approach integrate physical exercise , nutritional intake , polyunsaturated n-3 fatty acid ( n-3 PUFA ) , anabolizing hormone , privilege . A recent trial show clinical benefit approach patient chronic respiratory insufficiency ( CRI ) , similar nutritional muscular characteristic . Exercise rehabilitation well validated CHF patient , never validate case undernutrition . Exercise rehabilitation allow improve exercise capacity , quality life cardiovascular outcome include mortality . N-3 PUFA supplementation improve muscle strength endurance CRI patient . n-3 PUFA supplementation decrease 30 % cardiovascular mortality CHF patient . n-3 PUFA could useful CHF patient rehabilitation . Androgenopenia prognostic factor CHF . Androgen substitution improve significantly muscle strength , walk endurance quality life . In context multimodal approach , Androgen substitution together exercise rehabilitation ONS could beneficial effect muscle mass , strength endurance CHF patient , already describe CRI , elderly HIV patient . The study hypotheses 3-month multimodal approach associate exercise rehabilitation , androgen substitution , n-3 PUFAs ONS improve exercise capacity undernourish CHF patient .</brief_summary>
	<brief_title>Multimodal Approach Undernutrition Chronic Heart Failure</brief_title>
	<detailed_description>Study aim : Main study aim : To evaluate impact 3-month multimodal approach associate exercise rehabilitation , androgen substitution , n-3 PUFAs ONS exercise capacity undernourish CHF patient . Secondary study aim : To Evaluate impact 3-month multimodal approach : heart function muscle strength exercise endurance body composition nutritional status quality life drug compliance number hospital stay one year 1-year survival . Experimental protocol Undernourished CHF patient randomize two group : 1 ) The 'intervention ' group : 3-month multimodal approach associate exercise rehabilitation , ONS , n-3 PUFAs androgen substitution . 2 ) The 'control ' group : multimodal approach treatment currently recommend : heart rehabilitation dietary counsel 3 month . Both group receive oral route 3 month : vitamin D : 100 000UI/month plasma 25-OH vitamin D &lt; 30 ng/l , ubiquinone : 250 mg/jour patient . Both group benefit dietary counseling . A monthly follow-up compliance perform 3- month treatment period . The overall follow-up period 15 month , include 3-month treatment period . Considering recruitment period 18 month 15-month follow , total study duration 33 month . Primary endpoint : measurement VO2 ventilatory level . The study hypothesis demonstrate population malnourish CHF patient 10 % difference ( 15 % standard error ) level VO2 variation two group , measure maximal cycle exercise capacity test couple respiratory exchange . VO2 measure operator , baseline 3-month multimodal approach . Number subject include : 50 patient per group need demonstrate 10 % difference ( 15 % standard error ) 1st 2nd error risk respectively fix 5 % ( bilateral ) 10 % . Considering potential study dropout , 120 patient include . Inclusion criterion : Stable patient CHF , define absence acute episode since 2 month , absence exercise rehabilitation two last month NYHA III Heart failure VO2 peak &lt; 18 ml/kg/min Left ventricle ejection fraction ≤ 40 % Age ≥ 18 year , inform , give consent Absence acute disease Undernutrition , define : Involuntary weight loss ≥5 % 12 last month , without increase diuretic dose body mass index &lt; 20 fat-free mass index assess BIA &lt; 18 men , &lt; 15 woman . Exclusion criterion : Heart failure relate pulmonary hypertension Heart failure treatable surgery angioplasty Patients eligible ventricular resynchronisation Instable heart failure Patients wait transplantation On-going imunosuppressant corticosteroid Disease affect 6-month survival ( end-stage cancer , chronic disease , … ) Positive VIH hepatitis C serology Liver failure Respiratory insufficiency End-stage ( stage 5 ) renal failure ( creatinine clearance ≤15ml/kg/min ) Acute disease Previous history hormonal cancer ( breast , prostate ) Suspected proved hormonal cancer ( breast , prostate ) Hypersensibility testosterone component testosterone patch Liver tumor previous history liver tumor Unability contra-indication rehabilitation program ( defined French society Cardiology include contra-indication physical exercise ) Orthopedical limitation exercise Type 2 diabetes require insulin since less 3 month Patients give consent . Statistical analysis STATA V10 ( Stata Corp ) use . The analysis perform intention-to-treat , , secondly per-protocol . All statistical test ( except intermediary analysis ) perform consider 5 % α error risk . Continuous variable present mean standard deviation normal distribution ( Shapiro-Wilk test ) , median , quartile extremes , . Qualitative variable express n ( % ) . Comparisons group ( 1 ) systematic without adjustment , ( 2 ) adjustment factor equally distribute group despite randomization . Main endpoint , i.e . ventilatory peak VO2 , wil compare randomization group Student Kruskal-Wallis test . Variances equality test Fisher-Snedecor test . In case adjustment factor ( stratification treatment ) , linear regression model perform context secondary analysis . Secondary endpoint compare accord test Chi2 test exact Fisher test qualitative parameter . To measure variation time different collect parameter , longitudinal data analysis ANOVA repeat data , Friedman test , follow post-hoc test mixt model allow study inter- intra-patient variability . Intra-group comparison perform paired-t Student Wilcoxon test quantitative parameter Stuart-Maxwell test qualitative parameter . 12-month survival analysis perform accord : univariate analysis : comparison survival curve Kaplan-Meier method log-rank test multivariate analysis Cox model . Multivariate analysis model quality life ( e.g . SF36 ) consider group effect patient 's demographical/clinical data . To keep 5 % risk every analysed area , procedure 1st specie risk correction do calculate level significancy test . The rate expect miss data main endpoint estimate 20 % . A sensitivity analysis data perform evaluate statistical nature : MAR MCAR , necessary decide use appropriate method .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<criteria>Stable patient CHF , define absence acute episode since 2 month , absence exercise rehabilitation two last month NYHA III Heart failure VO2 peak &lt; 18 ml/kg/min Left ventricle ejection fraction ≤ 40 % Age ≥ 18 year , inform , give consent Absence acute disease Undernutrition , define : Involuntary weight loss ≥5 % 12 last month , without increase diuretic dose body mass index &lt; 20 fatfree mass index assess BIA &lt; 18 men , &lt; 15 woman . Heart failure relate pulmonary hypertension Heart failure treatable surgery angioplasty Patients eligible ventricular resynchronisation Instable heart failure Patients wait transplantation Ongoing imunosuppressant corticosteroid Disease affect 6month survival ( endstage cancer , chronic disease , … ) Positive VIH hepatitis C serology Liver failure Respiratory insufficiency Endstage ( stage 5 ) renal failure ( creatinine clearance ≤15ml/kg/min ) Acute disease Previous history hormonal cancer ( breast , prostate ) Suspected proved hormonal cancer ( breast , prostate ) Hypersensibility testosterone component testosterone patch Liver tumor previous history liver tumor Unability contraindication rehabilitation program ( defined French society Cardiology include contraindication physical exercise ) Orthopedical limitation exercise Type 2 diabetes require insulin since less 3 month Patients give consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Chronic heart failure</keyword>
	<keyword>Undernutrition</keyword>
	<keyword>Rehabilitation</keyword>
	<keyword>Physical exercise</keyword>
	<keyword>Nutrition</keyword>
	<keyword>n-3 fatty acid</keyword>
	<keyword>Androgen</keyword>
	<keyword>Testosterone</keyword>
</DOC>